Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02926690
Title Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoTherapy Science, Inc.
Indications

triple-receptor negative breast cancer

breast cancer

Therapies

OTS167

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Norwalk Hospital Recruiting Norwalk Connecticut 06856 United States Details
Weill Cornell Medicine | NewYork-Presbyterian Completed New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 11065 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field